- 2024-08-20 02:03抑制剂MK-5108|MK-5108|1010085-13-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂MK-3207|MK-3207|957118-49-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:03抑制剂MK-3207|MK-3207|957118-49-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂MK-3207|MK-3207|957118-49-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂MK-1026|Nemtabrutinib|2095393-15-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂MK2-IN-3|MK2-IN-3|724711-21-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:03抑制剂MK2-IN-3|MK2-IN-3|724711-21-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂MK2-IN-3|MK2-IN-3|724711-21-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂MK-0812|MK-0812|624733-88-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂MK-1026|Nemtabrutinib|2095393-15-8|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:03抑制剂MK-1026|Nemtabrutinib|2095393-15-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂MK-0812 Succinate|MK-0812 Succinate|851916-42-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:03抑制剂MK-0812 Succinate|MK-0812 Succinate|851916-42-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂MK-0812 Succinate|MK-0812 Succinate|851916-42-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂MK-0812|MK-0812|624733-88-6|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:03抑制剂MK-0608|MK-0608|443642-29-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:03抑制剂MK-0608|MK-0608|443642-29-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:03抑制剂MK-0608|MK-0608|443642-29-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂Mito-apocynin (C11)|Mito-apocynin (C11)|1254044-38-6|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:03抑制剂MitoBloCK-11 (MB-11)|MitoBloCK-11 (MB-11)|413606-16-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
